Article ; Online: The role of human C5a as a non-genomic target in corticosteroid therapy for management of severe COVID19.
Computational biology and chemistry
2021 Volume 92, Page(s) 107482
Abstract: Complement system plays a dual role; physiological as well as pathophysiological. While physiological role protects the host, pathophysiological role can substantially harm the host, by triggering several hyper-inflammatory pathways, referred as " ... ...
| Abstract | Complement system plays a dual role; physiological as well as pathophysiological. While physiological role protects the host, pathophysiological role can substantially harm the host, by triggering several hyper-inflammatory pathways, referred as "hypercytokinaemia". Emerging clinical evidence suggests that exposure to severe acute respiratory syndrome coronavirus-2 (SARS-CoV2), tricks the complement to aberrantly activate the "hypercytokinaemia" loop, which significantly contributes to the severity of the COVID19. The pathophysiological response of the complement is usually amplified by the over production of potent chemoattractants and inflammatory modulators, like C3a and C5a. Therefore, it is logical that neutralizing the harmful effects of the inflammatory modulators of the complement system can be beneficial for the management of COVID19. While the hunt for safe and efficacious vaccines were underway, polypharmacology based combination therapies were fairly successful in reducing both the morbidity and mortality of COVID19 across the globe. Repurposing of small molecule drugs as "neutraligands" of C5a appears to be an alternative for modulating the hyper-inflammatory signals, triggered by the C5a-C5aR signaling axes. Thus, in the current study, few specific and non-specific immunomodulators (azithromycin, colchicine, famotidine, fluvoxamine, dexamethasone and prednisone) generally prescribed for prophylactic usage for management of COVID19 were subjected to computational and biophysical studies to probe whether any of the above drugs can act as "neutraligands", by selectively binding to C5a over C3a. The data presented in this study indicates that corticosteroids, like prednisone can have potentially better selectively (K |
|---|---|
| MeSH term(s) | Binding Sites ; COVID-19/pathology ; Complement C5a/antagonists & inhibitors ; Complement C5a/chemistry ; Gene Expression Regulation/drug effects ; Humans ; Molecular Docking Simulation ; Prednisone/chemistry ; Protein Binding ; Protein Conformation ; SARS-CoV-2 ; COVID-19 Drug Treatment |
| Chemical Substances | Complement C5a (80295-54-1) ; Prednisone (VB0R961HZT) |
| Language | English |
| Publishing date | 2021-04-05 |
| Publishing country | England |
| Document type | Journal Article |
| ISSN | 1476-928X |
| ISSN (online) | 1476-928X |
| DOI | 10.1016/j.compbiolchem.2021.107482 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.